bonyf NV / Key word(s): Annual Results bonyf NV: bonyf’s 2023 financial statements made available 28-Jun-2024 / 17:12 CET/CEST
Dissemination of a Financial Wire News, transmitted by EQS Group. |
Factor D Inhibitor Wins Approval for PNH With Extravascular Hemolysis
The FDA approved the oral factor D inhibitor danicopan (Voydeya) as an add-on therapy to treat extravascular hemolysis in adults with paroxysmal nocturnal hemoglobinuria (PNH),